Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterized by an
abnormal reepithelialisation, an excessive tissue remodelling and a progressive fibrosis …

As a public health emergency of international concern, the highly contagious coronavirus
disease 2019 (COVID-19) pandemic has been identified as a severe threat to the lives of …

Artemisinin is the crucial ingredient of artemisia annua, a traditional Chinese medicine used
for the therapy of malaria in China for hundreds of years. In recent years, the anticancer …

Pulmonary fibrosis is a chronic, progressive, incurable interstitial lung disease with high
mortality after diagnosis and remains a global public health problem. Despite advances and …

Silicosis remains one of the most severe pulmonary fibrotic diseases worldwide, caused by
chronic exposure to silica dust. In this review, we have proposed that programmed cell death …

Respiratory inflammation is caused by an air‐mediated disease induced by polluted air,
smoke, bacteria, and viruses. The COVID‐19 pandemic is also a kind of respiratory disease …

Finasteride is an antiandrogenic drug used for the clinical treatment of chronic nonbacterial
prostatitis (CNP). Recently, we reported the anti-CNP activity of Poria cocos polysaccharides …

Background: Pulmonary fibrosis (PF) is a terminal pathological change in a variety of lung
diseases characterized by excessive deposition of extracellular matrix, for which effective …

Pulmonary fibrosis (PF) is a disease-refractive lung condition with an increased rate of
mortality. The potential factors causing PF include viral infections, radiation exposure, and …

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease, and its incidence rate is
rapidly rising. However, effective therapies for the treatment of IPF are still lacking …